• A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variants
• Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis
• Autoimmune diseases and new-onset atrial fibrillation: a UK Biobank study
• Cardiovascular risk in vasculitis
• Childhood rheumatic diseases: bites not only the joint, but also the heart
• Churg-Strauss Syndrome
• Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients
• Clinical genetics in 2014: New monogenic diseases span the immunological disease continuum
• COVID-19 Associated Vasculitis Confirmed by the Tissues RT-PCR: A Case Series Report
• Deficiency of adenosine deaminase 2: a challenging differential diagnosis of polyarteritis nodosa
• Factors associated with major cardiovascular events in patients with systemic necrotizing vasculitides: results of a longterm followup study
• Histiocytoid Sweet Syndrome Presenting in Two Sisters With Deficiency of Deaminase Type 2
• How to treat systemic necrotizing vasculitides?
• Infectious events during the course of systemic necrotizing vasculitis: a retrospective study of 82 cases
• Kidney Involvement in Autoinflammatory Diseases
• Microscopic Polyangiitis
• Mortality in systemic necrotizing vasculitides: A retrospective analysis of the French Vasculitis Study Group registry
• Pharmacokinetics of cyclophosphamide in patients with systemic necrotizing angiitis
• Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group
• Polyarteritis Nodosa
• Polyarteritis nodosa initially presenting as concomitant peripheral neuropathy and myositis in unilateral limb: A case report
• Risk of Stroke in Systemic Necrotizing Vasculitis: A Nationwide Study Using the National Claims Database
• Segmental arterial mediolysis: report of 2 cases and review of the literature
• Systemic necrotizing angitis, hypersensitivity vasculitis
• The "Viral" Form of Polyarteritis Nodosa (PAN)-A Distinct Entity: A Case Based Review
• Tofacitinib as monotherapy in cutaneous polyarteritis nodosa: a case series
• Treatment of systemic necrotizing vasculitides: recent advances and important clinical considerations
• Treatment of systemic necrotizing vasculitides: The 40-year experience of the French Vasculitis Study Group
• Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades
• Validation of the consensus methodology algorithm for the classification of systemic necrotizing vasculitis in Indian patients